Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature

At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Children
المؤلفون الرئيسيون:	Silvia Bloise, Alessia Marcellino, Vanessa Martucci, Mariateresa Sanseviero, Alessia Testa, Emanuela Del Giudice, Mattia Spatuzzo, Daniel Sermoneta, Flavia Ventriglia, Riccardo Lubrano
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2022-07-01
الموضوعات:	children vaccine SARS-CoV-2 adverse event lymphadenopathy
الوصول للمادة أونلاين:	https://www.mdpi.com/2227-9067/9/7/993